Determination of mRNA half-lives in Candida albicans using thiolutin as a transcription inhibitor

Genome

Volumn 49, Issue 8, 2006, Pages 894-899

  Kebaara, Bessie W ^a   Nielsen, Lindsey E ^a,b   Nickerson, Kenneth W ^a   Atkin, Audrey L ^a  

^a UNIVERSITY OF NEBRASKA   (United States)

^b IOWA STATE UNIVERSITY   (United States)

Author keywords

18S rRNA; ACT1; ADH1; Comparative mRNA stability; EFG1; mRNA decay; PGK1

Indexed keywords

2 PYRROLIDONE DERIVATIVE; FUNGAL RNA; MESSENGER RNA; PRIMER DNA; THIOLUTIN;

ARTICLE; CANDIDA ALBICANS; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HALF LIFE TIME; METABOLISM; NUCLEOTIDE SEQUENCE; SACCHAROMYCES CEREVISIAE;

BASE SEQUENCE; CANDIDA ALBICANS; DNA PRIMERS; HALF-LIFE; PYRROLIDINONES; RNA, FUNGAL; RNA, MESSENGER; SACCHAROMYCES CEREVISIAE; TRANSCRIPTION, GENETIC;

CANDIDA ALBICANS; FUNGI; SACCHAROMYCES CEREVISIAE;

EID: 33845453331     PISSN: 08312796     EISSN: None     Source Type: Journal    
DOI: 10.1139/G06-046     Document Type: Article

References (17)

1. Arnaud, M.B., Costanzo, M.C., Skrzypek, M.S., Binkley, G., Lane, C., Miyasato, S.R., and Sherlock, G. 2005. The Candida Genome Database (CGD), a community resource for Candida albicans gene and protein information. Nucleic Acids Res. 33(Database issue): D358-D363.
2. Berman, J., and Sudbery, P.E. 2002. Candida albicans: A molecular revolution built on lessons from budding yeast. Nat. Rev. Genet. 3(12): 918-930.
3. Bhattacharya, A., and Datta, A. 1975. Eukaryotic RNA: Its synthesis and decay in yeast cells. Proc. Symp. Struct. Funct. Aspects Chromosomes, pp. 393-404.
4. Bini, E., Dikshit, V., Dirksen, K., Drozda, M., and Blum, P. 2002. Stability of mRNA in the hyperthermophilic archaeon Sulfolobus solfataricus. RNA, 8: 1129-1136.
5. Fonzi, W.A., and Irwin, M.Y. 1993. Isogenic strain construction and gene mapping in Candida albicans. Genetics, 134: 717-728.
6. Gudlaugsson, O., Gillespe, S., Lee, K., Vande Berg, J., Hu, J., Messer, S., et al. 2003. Attributable mortality of nosocomial candidemia revisited. Clin. Infect. Dis. 37: 1172-1177.
7. Herrick, D., Parker, R., and Jacobson, A. 1990. Identification and comparison of stable and unstable mRNAs in Saccharomyces cerevisiae. Mol. Cell. Biol. 10(5): 2269-2284.
8. Jimenez, A., Tipper, D.J., and Davies, J. 1973. Mode of action of thiolutin, an inhibitor of macromolecular synthesis in Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 3(6): 729-738.
9. Kebaara, B., Nazarenus, T., Taylor, R., and Atkin, A.L. 2003. Genetic background affect relative nonsense mRNA accumulation in wild type and upf mutant yeast strains. Curr. Genet. 43: 171-177.
10. Li, B., Nierass, C.R., and Warner, J.R. 1999. Transcriptional elements involved in the repression of ribosomal protein Synthesis. Mol. Cell. Biol. 19(8): 5393-5404.
11. Macphail, G.L.P., Taylor, G.D., Bachanan-Chell, M., Ross, C., Wilson, S., and Kureishi, A. 2002. Epidemiology, treatment and outcome of candidemia; a five-year review at three Canadian hospitals. Mycoses, 45: 141-145.
12. Magee, P.T., Gale, C., Berman, J., and Davis, D. 2003. Molecular genetic and genomic approaches to the study of medically important fungi. Infect. Immun. 71(5): 2299-2309.
13. Nonet, M., Scafe, C., Sexton, J., and Young, R. 1987. Eucaryotic RNA polymerase conditional mutant that rapidly ceases mRNA synthesis. Mol. Cell. Biol. 7(5): 1602-1611.
14. Odds, F.C. 1988. Candida and Candidosis. 2nd ed. Bailliere Tindall, London, United Kingdom.
15. Ross, J. 1995. mRNA stability in Mammalian cells. Microbiol. Rev. 59(3): 423-450.
16. Stoldt, V.R., Sonneborn, A., Leuker, C.E., and Ernst, J. 1997. Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi. EMBO J. 16: 1982-1991.
17. Wang, Y., Liu, C.L., Storey, J.D., Tibshirani, R.J., Herschlag, D., and Brown, P.O. 2002. Precision and functional specificity in mRNA decay. Proc. Natl. Acad. Sci. U.S.A. 99(9): 5860-5865.